CIK 0001704292 · Large accelerated filer
Zai Lab Ltd
Sign in to watch- Ticker
- ZLAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 862161632588
- Business address
- 899 HALEI ROAD, BUILDING B, PUDONG, SHANGHAI, China
- Former names
- Zai Lab Ltd
- Open-market buys, last 90 days
- $33,389
- in 1 filing
- Open-market sales, last 90 days
- $7,020
- in 1 filing, $7K under 10b5-1 plans
Net +$26,369. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-28 | Edmondson Frazor Titus III Chief Legal Officer | Sale 10b5-1 | −14,544 | $32.98 | $480K | 14,328 |
| 2025-02-28 | Lis William Director | Sale 10b5-1 | −15,000 | $32.98 | $495K | 38,089 |
| 2025-02-28 | Du Ying Chairperson & CEO | Option exercise 10b5-1 | +50,000 | $0.60 | $30K | 544,117 |
| 2025-02-28 | Du Ying Chairperson & CEO | Sale 10b5-1 | −2,857 | $33.59 | $96K | 541,260 |
| 2025-02-28 | Du Ying Chairperson & CEO | Sale 10b5-1 | −46,943 | $34.52 | $1.6M | 494,317 |
| 2025-02-28 | Du Ying Chairperson & CEO | Sale 10b5-1 | −200 | $35.06 | $7K | 494,117 |
| 2025-02-28 | Du Ying Chairperson & CEO | Option exercise · Stock Options (Right to Buy) 10b5-1 | −50,000 | 539,165 | ||
| 2024-12-31 | Chen Kai-Xian Director | Returned to the company | −21,253 | 39,525 | ||
| 2024-12-31 | Amado Rafael See Remarks | Sale | −7,583 | $26.28 | $199K | 33,834 |
| 2024-12-30 | Amado Rafael See Remarks | Option exercise | +21,000 | 41,417 | ||
| 2024-12-30 | Amado Rafael See Remarks | Option exercise · Restricted Share Units | −21,000 | 63,000 | ||
| 2024-12-11 | Du Ying Chairperson & CEO | Gift | −500,000 | 494,117 | ||
| 2024-11-04 | Chen Yajing Chief Financial Officer | Sale | −167 | $30.66 | $5K | 15,494 |
| 2024-11-01 | Chen Yajing Chief Financial Officer | Option exercise | +500 | 15,661 | ||
| 2024-11-01 | Chen Yajing Chief Financial Officer | Option exercise · Restricted Share Units | −500 | 500 | ||
| 2024-10-02 | Chen Yajing Chief Financial Officer | Sale | −301 | $25.40 | $8K | 15,161 |
| 2024-10-01 | Chen Yajing Chief Financial Officer | Option exercise | +920 | 15,462 | ||
| 2024-10-01 | Chen Yajing Chief Financial Officer | Option exercise · Restricted Share Units | −920 | 1,840 | ||
| 2024-09-03 | GAYNOR RICHARD Director | Sale 10b5-1 | −2,500 | $19.50 | $49K | 46,568 |
| 2024-08-19 | Edmondson Frazor Titus III Chief Legal Officer | Sale | −1,924 | $16.95 | $33K | 28,872 |
Page 16 of 28 · 554 trades